De Simone is a Ghanaian indigenous company that started operating in 1964 and has since expanded into various sectors such as power, mining and oil & gas, and currently operates in Ghana, Ivory Coast, Burkina Faso, Nigeria, Liberia, Mali and Guinea.
Evonik enjoys rapid growth in Mexico across all sectors, both in market share for existing products and as a result of acquisitions and diversification.
Sanofi has a diversified portfolio, ranging from innovative medicines including rare diseases, immunology, diabetes and cardiovascular to consumer healthcare products and vaccines.
CHIEF SENIOR RESEARCHER, TUBITAK MAM, GENETIC ENGINEERING AND BIOTECHNOLOGY INSTITUTE (GEBI)
The Genetic Engineering and Biotechnology Institute (GEBI) conducts researches and develops technologies in the field of genetic engineering and biotechnology with high added value by taking into consideration the developments in the world and the needs of the public and industrial sectors in Turkey.
TR-PHARM, founded in 2013, is a marketer of pharmaceuticals and biopharmaceuticals with a focus on high-tech R&D and the ambition to gain global recognition in bringing high-quality and cost-effective solutions in the healthcare industry.
Active since 1958, DEVA is a generics company with approximately 600 products ranging from APIs, formulations, sterile injectables and ampoules, BFS eye drops and animal health products.
Featuring insights from nearly 120 mining executives, the second pre-release edition of GBR's Peru Mining 2025 sheds light on the industry's current state while highlighting Peru’s window of opportunity to align with the global energy transition and copper’s increasingly critical role.